Search Results - "Zumschlinge, R"

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer by LORDICK, F, LORENZEN, S, SERONEIT, T, BREDENKAMP, R, DUYSTER, J, PESCHEL, C, STOLLFUSS, J, VEHLING-KAISER, U, KULLMANN, F, HENTRICH, M, ZUMSCHLINGE, R, DIETZFELBINGER, H, THOEDTMANN, J, HENNIG, M

“…Oxaliplatin plus fluorouracil/folinic acid (5-FU/FA) every 2 weeks has shown promising activity in advanced gastric cancer. This study assessed the efficacy…”
Get full text

Ifosfamide, carboplatin and etoposide combined with 41.8 °C whole body hyperthermia for malignant pleural mesothelioma by Bakhshandeh, A, Bruns, I, Traynor, A, Robins, H.I, Eberhardt, K, Demedts, A, Kaukel, E, Koschel, G, Gatzemeier, U, Kohlmann, Th, Dalhoff, K, Ehlers, E.M, Gruber, Y, Zumschlinge, R, Hegewisch-Becker, S, Peters, S.O, Wiedemann, G.J

“…We performed a phase II study combining 41.8 °C whole body hyperthermia with ICE chemotherapy, i.e. ifosfamide (5 g/m 2), carboplatin (300 mg/m 2) and…”
Get full text

Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia' by Hildebrandt, B, Hegewisch-Becker, S, Kerner, T, Nierhaus, A, Bakhshandeh-Bath, A, Janni, W, Zumschlinge, R, Sommer, H, Riess, H, Wust, P

“…The term 'extreme' whole-body hyperthermia (WBH) describes the procedure of raising a patients' body-core temperature to 41.5-42.0 degrees C for 60 min. WBH…”
Get more information

Randomized trial with ICE (ifosfamide, carboplatin, etoposide) plus whole body hyperthermia versus ICE chemotherapy for malignant pleural mesothelioma by Bakhahandeh, A., Wiedemann, G., Zabel, P., Dalhoff, K., Kohlmann, T., Zumschlinge, R., Penzel, D., Wagner, T., Peters, S.

“…Abstract only…”
Get full text

Randomized trial with ICE (ifosfamide, carboplatin, etoposide) plus whole body hyperthermia versus ICE chemotherapy for malignant pleural mesothelioma by Bakhahandeh, A., Wiedemann, G., Zabel, P., Dalhoff, K., Kohlmann, T., Zumschlinge, R., Penzel, D., Wagner, T., Peters, S.

“…Abstract only…”
Get full text

Oxaliplatin plus 5FU/folinic acid (FUFOX Regimen) in 1 st line metastatic gastric cancer (MGC). Results of the Multicenter Phase II STOMOX Trial by Duyster, J., Lorenzen, S., Kullmann, F., Hentrich, M., Zumschlinge, R., Vehling-Kaiser, U., Seroneit, T., Bredenkamp, R., Peschel, C., Lordick, F.

“…Abstract only…”
Get full text

Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma by Bakhshandeh, A, Bruns, I, Traynor, A, Robins, H I, Eberhardt, K, Demedts, A, Kaukel, E, Koschel, G, Gatzemeier, U, Kohlmann, Th, Dalhoff, K, Ehlers, E M, Gruber, Y, Zumschlinge, R, Hegewisch-Becker, S, Peters, S O, Wiedemann, G J

“…We performed a phase II study combining 41.8 degrees C whole body hyperthermia with ICE chemotherapy, i.e. ifosfamide (5 g/m(2)), carboplatin (300 mg/m(2)) and…”
Get full text